hDMT partner Minacned

About hDMT

The Institute for human Organ and Disease Model technologies (hDMT) is a precompetitive non-profit technological R&D institute, initiated in the Netherlands. hDMT integrates state-of-the-art human stem cell technologies with top level engineering, physics, chemistry, biology, clinical and pharmaceutical expertise from academia and industry to develop and valorize human organ and disease models-on-a-chip.

Human test model systems

These miniature models in chip format closely mimic human tissue and organs in vivo. This will primarily meet the need for representative human test model systems for drug development and other applications, and as an additional goal also will reduce the use of animal experiments. hDMT will engage in close dialogue with pharmaceutical and other companies to tune the scientific program to their needs for specific organ and disease models. Within the hDMT Institute also the ‘scalability and manufacturability’ of the technologies will be addressed.

Virtual institute

hDMT combines technologies, facilities and expertise from different disciplines and multiple organizations and locations, thereby forming a virtual institute, ‘a laboratory without walls’. hDMT is a public-private consortium of 9 founding partners, including the three Universities of Technology (Twente, Eindhoven, Delft), the Leiden University and University Medical Centre, Erasmus Medical Centre, the Hubrecht Institute, and two companies Genmab and Galapagos. As a central point of contact hDMT is envisaged as the gateway for pharmaceutical companies to ‘Organ on chip’ technology in the Netherlands, supported by world class stem cell science. hDMT will consolidate expertise in the Netherlands and collaborate with experts from abroad in this area to develop complementary international programs that will lead to new insights in human disease, and to new treatments and diagnostic tests.

Contact

hDMT
If you have any practical questions regarding hDMT, please send an e-mail: info@hdmt.technology.
For all other questions contact Managing Director Janny van den Eijnden – van Raaij: j.vandeneijnden@hdmt.technology or call +31(0)6 1299 8074.

Gepubliceerde artikelen

SMART Photonics secures €35M new funding

SMART Photonics is excited to announce a €35M Series C investment…
3 juli 2020/door Aurélie Veltema

2020 LIFE call for proposals for traditional projects – environment and resource efficiency

Please read the message on the measures relating to the COVID-19…
2 juli 2020/door Aurélie Veltema

KIEM 2020 open

Hogescholen en universitaire onderzoekers kunnen financiering…
29 juni 2020/door Aurélie Veltema

Funding for projects within Open Technology Programme and Take-off

In June, the board of NWO Domain Applied and Engineering Sciences…
25 juni 2020/door Aurélie Veltema

New insights into the energy levels in quantum dots

(Nanowerk News) Researchers from Basel, Bochum and Copenhagen…
25 juni 2020/door Aurélie Veltema

Organ-on-chip test effect COVID-19 op het hart

Niet alleen de longen ondervinden ernstige schade door COVID-19,…
22 juni 2020/door Aurélie Veltema

FME onderzoek: Technologische industrie aan vooravond recessie

Derde kwartaal 2020 absoluut dieptepunt
Uit onderzoek van FME…
19 juni 2020/door Aurélie Veltema

Meer dan € 30 miljoen voor 9 Nederlandse innovatieve scale-ups

Nieuwe manieren om patiënten te beademen zodat er minder schade…
18 juni 2020/door Aurélie Veltema

Upfield and Beyond Meat choose the Netherlands as New Plant-Based Industrial Hub

Plantbased leader Upfield announced plans to build a new…
17 juni 2020/door Aurélie Veltema

MIT: R&D collaborative projects open

Do you work with other SME's to develop or renew products,…
11 juni 2020/door Aurélie Veltema

International MicroNanoConference 2020 online

On December 3 and 4 2020, the international MicroNanoConference…
10 juni 2020/door Aurélie Veltema

New MinacNed Board with ambition for growth and more opportunities for MinacNed community

MinacNed has a new board overseeing all activities, with a new…
9 juni 2020/door Aurélie Veltema